FemTech.Live Monthly Investment Roundup

Our monthly roundup of all the need-to-know news and expert insights into investment in the FemTech space.

This month saw FemTech focused funds, multi-million-pound investments and corporate partnerships within the FemTech space. So we’re bringing you the latest market insights from expert advisors in investment, digital health and technology.

Opportunity Insights

Investors Guide to FemTech
Read more investment insights in our series: Unlocking the Blue Ocean: A Guide to FemTech for Investors

Green Flags for Investment – Dr Jane Van Dis said that “a founder team that understands its competitive landscape and is dedicated to the mission of improving womens’ lives” would always be a sure bet investment.

Gender Gap in Finance – Anna-Sophie Hartvigsen, co-founder of Female Invest, said “the frustrating thing about the gender gap in finance is that many of the underlying causes are rooted in systemic issues. However, the one area women can impact themselves (today) is how they manage their money.”

Investment News

The global home insemination market size is forecast to reach $2.3 billion by 2025, growing at a CAGR of 6.8% during the forecast period 2020-2025.

The Women’s Health Diagnostics Market is Projected to Reach $36.6 billion by 2025.

The Case for Her, a philanthropic investment portfolio addressing the key women’s health issues of menstruation and sexual health and pleasure, announced that Shannon Lovgren will join as Managing Director effective April 1, 2021. 

Read more insights and opportunities via our investment page.

Frost & Sullivan identified five critical success factors for the FemTech market to thrive.

Bellabeat launch $10 million fund to bring more attention to postnatal depression as well as incentivize institutes, companies, and clinics in the space to look for viable, holistic health solutions regarding the issue that is postnatal depression.

Healthy Pleasure Group (HPG), the global outfit dedicated solely to Sexual Health and Technology launches Amboy Street Ventures (ASV), the world’s first venture capital fund currently in the market focused on Sexual Health (for all genders) and Women’s Health Technology start-ups.

Previous Post

Yoppie Raises £3.4m from High Profile Investors

Next Post

Study Explores How Religious Congregations Shape Women’s Health

Related Posts

Subscribe to our newsletter!

Subscribe to our newsletter!